IDO1 and ovarian cancer: Expression of both B7-H1 and IDO are associated with differentiation and recruitment of Treg (7–9), and clinical studies have shown that each of these mechanisms correlates independently with increased morbidity and mortality in ovarian cancer patients (10–12).